Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptargroup (ATR) Accumulated Expenses (2010 - 2019)

Aptargroup (ATR) reported Accumulated Expenses of $163.8 million for Q4 2019, down 2.68% year-over-year from $168.3 million in Q4 2018, and down 2.68% on a QoQ basis from $168.3 million in Q4 2018.

Aptargroup (ATR) has 10 years of Accumulated Expenses data on file, last reported at $163.8 million in Q4 2019.

  • Quarterly Accumulated Expenses fell 2.68% year-over-year to $163.8 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $163.8 million (down 2.68% YoY) and the FY2019 annual result came in at $163.8 million, down 2.68% from the prior year.
  • Accumulated Expenses eased to $163.8 million in Q4 2019 per ATR's latest filing, from $168.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $168.3 million in Q4 2018 and bottomed at $119.8 million in Q4 2016.
  • The 5-year median for Accumulated Expenses is $144.2 million (2017), against an average of $144.4 million.
  • The widest annual swing landed in 2016, when Accumulated Expenses slipped 4.74%; it then increased 20.38% in 2017.
  • Tracing ATR's Accumulated Expenses over 5 years: stood at $125.7 million in 2015, then declined by 4.74% to $119.8 million in 2016, then advanced by 20.38% to $144.2 million in 2017, then grew by 16.77% to $168.3 million in 2018, then dropped by 2.68% to $163.8 million in 2019.
  • Per Business Quant, the three latest ATR Accumulated Expenses figures stand at $163.8 million (Q4 2019), $168.3 million (Q4 2018), and $144.2 million (Q4 2017).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 163.84 Mn
Dec 31, 2018 168.35 Mn
Dec 31, 2017 144.18 Mn
Dec 31, 2016 119.77 Mn
Dec 31, 2015 125.72 Mn
Dec 31, 2014 125.23 Mn
Dec 31, 2013 126.85 Mn
Dec 31, 2012 120.69 Mn
Dec 31, 2011 114.72 Mn
Dec 31, 2010 95.33 Mn